Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001477932-16-011373
Filing Date
2016-07-14
Accepted
2016-07-14 17:19:58
Documents
62
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K nbio_10k.htm 10-K 502405
2 CERTIFICATION nbio_ex311.htm EX-31.1 7388
3 CERTIFICATION nbio_ex312.htm EX-31.2 7440
4 CERTIFICATION nbio_ex321.htm EX-32.1 2988
5 CERTIFICATION nbio_ex322.htm EX-32.2 2988
  Complete submission text file 0001477932-16-011373.txt   2589304

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nbio-20160331.xml EX-101.INS 467526
7 XBRL TAXONOMY EXTENSION SCHEMA nbio-20160331.xsd EX-101.SCH 38706
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nbio-20160331_cal.xml EX-101.CAL 37936
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nbio-20160331_def.xml EX-101.DEF 63335
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nbio-20160331_lab.xml EX-101.LAB 191518
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nbio-20160331_pre.xml EX-101.PRE 155585
Mailing Address 601 21ST STREET SUITE 300 VERO BEACH FL 32960
Business Address 601 21ST STREET SUITE 300 VERO BEACH FL 32960 612-961-5656
Nascent Biotech Inc. (Filer) CIK: 0001622057 (see all company filings)

EIN.: 450612715 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 000-55299 | Film No.: 161768021
SIC: 2834 Pharmaceutical Preparations